Found 6 results
Filters: Keyword is Amyloid beta-Peptides  [Clear All Filters]
2019
Schilling LPorcello, Pascoal TA, Zimmer ER, Mathotaarachchi S, Shin M, Rieder CRoberto de, Gauthier S, Palmini A, Rosa-Neto P.  2019.  Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.. Mol Neurobiol. 56(7):4916-4924.
Ishii M, Kamel H, Iadecola C.  2019.  Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.. J Alzheimers Dis. 67(1):257-263.
2018
Walters MJ, Sterling J, Quinn C, Ganzer C, Osorio RS, Andrews RD, Matthews DC, Vallabhajosula S, de Leon MJ, Isaacson RS et al..  2018.  Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.. BMJ Open. 8(11):e023664.
Mosconi L, Rahman A, Diaz I, Wu X, Scheyer O, Hristov HWebb, Vallabhajosula S, Isaacson RS, de Leon MJ, Brinton RDiaz.  2018.  Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.. PLoS One. 13(12):e0207885.
2010
Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S et al..  2010.  Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.. Proc Natl Acad Sci U S A. 107(13):5949-54.
Mosconi L, Glodzik L, Mistur R, McHugh P, Rich KE, Javier E, Williams S, Pirraglia E, De Santi S, Mehta PD et al..  2010.  Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's.. Biol Psychiatry. 68(10):913-21.